Research Article Cites HemogloBind™ in Cholinesterase Analysis for Evaluating Oxime Therapies

Research Article Cites HemogloBind™ in Cholinesterase Analysis for Evaluating Oxime Therapies

News Release

MONMOUTH JUNCTION, NJ, November 14, 2014 — Biotech Support Group reports on a recent research article which describes the simplicity and efficiency of their proteomic sample preparation technology for hemoglobin depletion. The citation is:

Christina M. Wilhelm, Thomas H. Snider, Michael C. Babin, David A. Jett, Gennady E. Platoff Jr., David T. Yeung. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides. Toxicology and Applied Pharmacology
Available online 31 October 2014. doi:10.1016/j.taap.2014.10.009

Acetylcholine is an essential neurotransmitter, and inhibitors of cholinesterases(ChEs) are potent toxins. The objective of the present study is to identify an oxime antidote, under standardized and comparable conditions, that offers protection against chemical warfare agents or pesticides. Clinical signs of toxicity were observed for 24 h post challenge and blood cholinesterase [AChE and butyrylcholinesterase (BChE)] activity was analyzed utilizing a modified Ellman’s method. In the modified Ellman’s enzymatic assay for evaluating ChE activity, HemogloBind™, Biotech Support Group’s unique solid-phase polymer for hemoglobin depletion, was used for pre-treatment. The article states “Terminal blood samples were collected and processed for all survivors using HemogloBind™”.

“As hemoglobin interference is common in many enzymatic assays, I am pleased to see the successful use of HemogloBind™for both efficient hemoglobin depletion along with retention of functional activity post-treatment.” states Swapan Roy, Ph.D., President and Founder of Biotech Support Group.
http://www.biotechsupportgroup.com/node/75

About Biotech Support Group LLC
Biotech Support Group LLC is a leading provider of genomics and proteomics sample preparation products and enrichment reagent kits as well as integrated biotechnology services for life sciences research, biomarker and drug discovery. Based in New Jersey, it’s principal products include: AlbuSorb™ & AlbuVoid™ for albumin depletion,Cleanascite™ for lipid adsorption and clarification, HemogloBind™ & HemoVoid™ for hemoglobin removal, NuGel™ for functional & chemical proteomics, andProCipitate™ & ProPrep™ for nucleic acid isolation. For more information, go to http://www.biotechsupportgroup.com

CONTACT:
Dr. Swapan Roy & Matthew Kuruc
Biotech Support Group LLC
1 Deer Park Drive, Suite M
Monmouth Junction NJ 08852
732-274-2866 Worldwide
800-935-0628 North America
sales@biotechsupportgroup.com
http://www.biotechsupportgroup.com
*For research use only

Posted on Date:
Tue, 11/18/2014